Malignant pleural effusion (MPE), the presence of malignant cells in pleural fluid, is often the
first sign of many cancers and occurs in patients with metastatic malignancies. Accurate …

ABSTRACT A malignant pleural effusion (MPE) establishes an incurable stage of a
malignancy. Median survival after detection of an MPE is 4 to 6 months in general …

The treatment of stage IIIA non–small cell lung cancer and subsequently resectable stage
IIIB disease has evolved over the last 30 years. Before the advent of the cisplatin era that …

Malignant pleural effusion (MPE) accompanying lung adenocarcinoma indicates poor
prognosis and early metastasis. This study aimed to identify genes related to MPE formation …

Pleural malignancies, including primary malignant pleural mesothelioma and secondary
pleural metastasis of various tumours resulting in malignant pleural effusion, are frequent …

Pleural effusions present a challenge for both diagnosis and treatment. They are a
commonly presenting problem of a wide range of local and systemic potentially life …

Central airway obstruction refers to significant obstruction of the trachea and main bronchi.
Patients with advanced-stage lung cancer who have this complication are likely to have …

Lung cancer is among the most common and lethal cancers around the world. Most lung
cancers are directly attributed to smoking. 1 Common histologic subtypes of lung …

The PET scanner has its place in the pleura imaging: it can be used in the diagnose of
benign and malignant pleural diseases (threshold SUV= 2.2). It improves the staging of …

This thesis consists of 3 studies: 1. Determination of the minimal important difference (MID)
of the visual analogue scale for dyspnoea (VASD): Determining the MID of the VASD is …